Patents by Inventor Martins Priede

Martins Priede has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220119348
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Application
    Filed: October 29, 2021
    Publication date: April 21, 2022
    Applicant: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • Patent number: 11161815
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: November 2, 2021
    Assignee: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • Patent number: 11028067
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: June 8, 2021
    Assignee: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • Publication number: 20200239417
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Application
    Filed: February 7, 2018
    Publication date: July 30, 2020
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • Publication number: 20200223819
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Application
    Filed: February 7, 2018
    Publication date: July 16, 2020
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede